Agios Pharmaceuticals Inc (NASDAQ: AGIO) stock suffered a major decline of -11.0% on 9/4/25. The shares closed at $36.13. Moreover, exceptionally high trading volume at 373% of normal accompanied the decline. The stock has performed in line with the market over the last nine months and has declined -6.1% during the last week.
Current PriceTarget Research Rating
Agios Pharmaceuticals has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Agios Pharmaceuticals has a slightly negative Appreciation Score of 36 and a slightly negative Power Rating of 30, triggering the Negative Value Trend Rating.
Rating Review
In light of this highly negative price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment